The Centers for Medicare & Medicaid Services has announced an error in calculating Clostridium difficile infection performance during the first two quarters of 2014.

This error affects hospital performance in the fiscal year 2017 Hospital Acquired Condition Reduction Program, baseline performance in the FY 2018 hospital value-based purchasing program, and measure data reported on Hospital Compare in 2015.

As a result, CMS is conducting a second review and corrections period for the FY 2017 HAC program from today through Sept. 30 to allow hospitals to review their updated C Difficile performance.

CMS also has updated the baseline period performance standard for the FY 2018 VBP program, and intends to update the archived databases of Hospital Compare to reflect corrected performance data.

For more information, see CMS’s QualityNet website.

Related News Articles

Headline
WellSpan Health in York, Pa., will receive the 2024 AHA Quest for Quality Prize for its commitment to improving quality through its health equity strategic…
Headline
Antimicrobial-resistant infections remained above pre-pandemic levels in 2022, the Centers for Disease Control and Prevention reported July 16. CDC data show…
Headline
The Centers for Disease Control and Prevention July 14 announced four confirmed human cases of H5N1 bird flu among farm workers who were working at a Colorado…
Perspective
Patient safety is the top priority of every caregiver. Hospitals and health systems never stop searching for ways to improve quality, performance and results…
Blog
The greatest success story of the 20th century is longevity. This is especially true in the United States, where average life expectancy at birth rose by more…
Headline
The AHA the week of July 8 released its Quality Collective Report, which explores quality, safety and performance improvement strategies and insights from…